InvestorsObserver
×
News Home

Hims & Hers Health Inc Up 29.6% To $13.32 After Earnings Beat

Tuesday, February 27, 2024 10:48 AM | InvestorsObserver Analysts

Mentioned in this article

Hims & Hers Health Inc Up 29.6% To $13.32 After Earnings Beat

Tuesday, February 27, 2024 - Hims & Hers Health Inc (HIMS) reported upside earnings and revenues today.

Hims & Hers Health Inc's earnings came in at an EPS of $0.01 per share, 150.00% higher than estimates for an EPS loss of $0.02 per share. The firm's earnings are up 120% since reporting losses of $0.05 per share in the same period a year ago.

Revenues were upbeat at $246.6 million. That is an increase of 47.50% in revenues from the year-ago report and is 0.33% higher than consensus estimates set at $245.8 million.

The stock is up 29.6% to $13.32 after the report.

The firm's lower revenue growth to earnings signals that the firm has been able to reduce costs and improve its profit margin overall.

Wall Street Analysts had an average rating of Buy on the stock prior to the report.

Trading in the five days leading up to the report earned Hims & Hers Health Inc a Bullish Sentiment Rank from InvestorsObserver.

Hims & Hers Health Inc has performed a little above average during the past few months. Before the report, Hims & Hers Health Inc received a Long-Term Technical Rank by InvestorsObserver of 61, putting it in the top half of stocks. The firm set a 52-week low on October 30, 2023 at $5.65 and set a 52-week high on May 8, 2023 at $12.34.

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App